Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Ventyx Biosciences, Inc. Common Stock (NASDAQ: VTYX)

 
VTYX Technical Analysis
5
As on 9th Jun 2023 VTYX STOCK Price closed @ 33.21 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 18.88 & Strong Buy for SHORT-TERM with Stoploss of 14.43 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

VTYXSTOCK Price

Open 34.75 Change Price %
High 35.35 1 Day -1.62 -4.65
Low 32.55 1 Week -1.26 -3.66
Close 33.21 1 Month -3.34 -9.14
Volume 570352 1 Year 18.07 119.35
52 Week High 46.65 | 52 Week Low 10.00
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
VTYX
Daily Charts		 VTYX
Intraday Charts		 Whats New @
Bazaartrend		 VTYX
Free Analysis
 
VTYX Important Levels Intraday
RESISTANCE38.61
RESISTANCE36.88
RESISTANCE35.81
RESISTANCE34.74
SUPPORT31.68
SUPPORT30.61
SUPPORT29.54
SUPPORT27.81
 
VTYX Forecast April 2024
Share
4th UP Forecast47.49
3rd UP Forecast42.91
2nd UP Forecast40.08
1st UP Forecast37.25
1st DOWN Forecast29.17
2nd DOWN Forecast26.34
3rd DOWN Forecast23.51
4th DOWN Forecast18.93
 
VTYX Weekly Forecast
4th UP Forecast42.67
3rd UP Forecast39.64
2nd UP Forecast37.76
1st UP Forecast35.89
1st DOWN Forecast30.53
2nd DOWN Forecast28.66
3rd DOWN Forecast26.78
4th DOWN Forecast23.75
 
VTYX Forecast2024
4th UP Forecast105.95
3rd UP Forecast82.62
2nd UP Forecast68.2
1st UP Forecast53.78
1st DOWN Forecast12.64
2nd DOWN Forecast-1.78
3rd DOWN Forecast-16.2
4th DOWN Forecast-39.53
 
 
VTYX Other Details
Segment EQ
Market Capital 988394112.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
VTYX Address
VTYX
 
VTYX Latest News
 
Your Comments and Response on Ventyx Biosciences, Inc. Common Stock
 
VTYX Business Profile
Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis, inflammatory bowel disease, psoriatic arthritis, and lupus. It also develops VTX002, an oral sphingosine 1 phosphate receptor 1 modulator that has completed phase I clinical trials for the treatment of ulcerative colitis; and VTX2735, a peripheral-targeted NOD-like receptor protein 3 (NLRP3) inflammasome inhibitor for the treatment of systemic inflammatory diseases, such as cardiovascular, hepatic, renal, and rheumatologic diseases. In addition, the company develops CNS-penetrant NLRP3 inhibitors. Ventyx Biosciences, Inc. was incorporated in 2018 and is based in Encinitas, California. Address:
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service